VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for Zentalis Pharmaceuticals Inc Common Stock (ZNTL)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Zentalis Pharmaceuticals Inc Common Stock
Symbol: ZNTL
Shares outstanding: 71,268,845 shares
Disclosed Ownership: 3,271,240 shares
Ownership: 4.59%
Form type: SCHEDULE 13G/A
Filing time: 31 Jan 2025, 10:09:52 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	4.59%	3,271,240	0	25,056	Ashley Grim	Head of Global Fund Administration